Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom.
Department of Respiratory Medicine, Institute for Lung Health, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.
Am J Kidney Dis. 2015 Aug;66(2):249-57. doi: 10.1053/j.ajkd.2014.10.019. Epub 2014 Dec 18.
Skeletal muscle wasting in chronic kidney disease (CKD) is associated with morbidity and mortality. Resistance exercise results in muscle hypertrophy in the healthy population, but is underinvestigated in CKD. We aimed to determine the feasibility of delivering a supervised progressive resistance exercise program in CKD, with secondary aims to investigate effects on muscle size, strength, and physical functioning.
Parallel randomized controlled feasibility study.
SETTING & PARTICIPANTS: Patients with CKD stages 3b to 4 were randomly assigned to the exercise (n=20; 11 men; median age, 63 [IQR, 57-65] years; median estimated glomerular filtration rate, 28.5 [IQR, 19.0-32.0] mL/min/1.73 m(2)) or nonexercise control (n=18; 14 men; median age, 66 [IQR, 45-79] years; estimated glomerular filtration rate, 20.5 [IQR, 16.0-26.0] mL/min/1.73 m(2)) group.
Patients in the exercise group undertook an 8-week progressive resistance exercise program consisting of 3 sets of 10 to 12 leg extensions at 70% of estimated 1-repetition maximum thrice weekly. Patients in the control group continued with usual physical activity.
Primary outcomes were related to study feasibility: eligibility, recruitment, retention, and adherence rates. Secondary outcomes were muscle anatomical cross-sectional area, muscle volume, pennation angle, knee extensor strength, and exercise capacity.
Two- and 3-dimensional ultrasonography of skeletal muscle, dynamometry, and shuttle walk tests at baseline and 8 weeks.
Of 2,349 patients screened, 403 were identified as eligible and 38 enrolled in the study. 33 (87%) completed the study, and those in the exercise group attended 92% of training sessions. No changes were seen in controls for any parameter. Progressive resistance exercise increased muscle anatomical cross-sectional area, muscle volume, knee extensor strength, and exercise capacity.
No blinded assessors, magnetic resonance imaging not used to assess muscle mass, lack of a healthy control group.
This type of exercise is well tolerated by patients with CKD and confers important clinical benefits; however, low recruitment rates suggest that a supervised outpatient-based program is not the most practical implementation strategy.
慢性肾脏病(CKD)患者存在骨骼肌消耗,与发病率和死亡率相关。在健康人群中,抗阻运动可导致肌肉肥大,但在 CKD 中的研究较少。本研究旨在确定在 CKD 患者中实施监督下的渐进式抗阻运动方案的可行性,次要目的是研究其对肌肉大小、力量和身体功能的影响。
平行随机对照可行性研究。
3b 期至 4 期 CKD 患者被随机分配至运动(n=20;11 名男性;中位年龄 63[IQR,57-65]岁;中位估算肾小球滤过率 28.5[IQR,19.0-32.0]mL/min/1.73m²)或非运动对照组(n=18;14 名男性;中位年龄 66[IQR,45-79]岁;估算肾小球滤过率 20.5[IQR,16.0-26.0]mL/min/1.73m²)。
运动组患者接受 8 周渐进式抗阻运动方案,包括每周 3 次,每次 3 组,每组 10-12 次 70%的估计 1 次重复最大重复伸膝运动。对照组患者继续进行常规体育活动。
主要结局与研究可行性相关:入选率、招募率、保留率和依从率。次要结局为肌肉解剖横截面积、肌肉体积、肌纤维角度、膝关节伸肌力量和运动能力。
基线和 8 周时进行骨骼肌 2 维和 3 维超声、测力和穿梭步行试验。
在筛选的 2349 名患者中,有 403 名被确定为符合条件的患者,其中 38 名患者入组。33 名(87%)完成了研究,运动组患者参加了 92%的训练课程。对照组患者的任何参数均未发生变化。渐进式抗阻运动增加了肌肉解剖横截面积、肌肉体积、膝关节伸肌力量和运动能力。
无盲法评估者、未使用磁共振成像评估肌肉质量、缺乏健康对照组。
这种类型的运动可被 CKD 患者耐受,并带来重要的临床获益;然而,低招募率表明,监督下的门诊基础方案并非最实用的实施策略。